Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents an uncharacterized antisense non-coding RNA transcript located on human chromosome 18, annotated as antisense to the PIGN (Phosphatidylinositol glycan anchor biosynthesis class N) gene. It is referenced in gene databases (NCBI, Ensembl) but has not been experimentally characterized for biological function, disease association, or pharmacology. The transcript does not code for a protein and has not been validated as a receptor, enzyme, transporter, or therapeutic target. Its annotation likely arises from automated transcript discovery in genomic studies, but no additional information is available regarding its structure or function at this time[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to PIGN (LOC105372159).